Executive Director, V&I Outcomes Research Oncology, Precision Medicine and Portfolio RWE

Role Summary The Executive Director, Value & Implementation (V&I) Outcomes Research, Oncology Precision Medicine and Portfolio RWE position resides in the V&I organization, which includes Global Medical and Scientific Affairs as well as Outcomes Research. This role leads real-world evidence generation that spans across the oncology portfolio to inform market decisions for our Company's oncology medicines and diagnostics/biomarkers, to support tumor, asset, and precision medicine value evidence strategy, and to demonstrate value in real-world settings. Under the guidance of a senior leader, this position leads a team of outcomes research professionals to develop value evidence strategies and generate real-world evidence that informs market decisions related to oncology medicines and associated diagnostics and biomarkers and demonstrates value in real world settings. The Executive Director provides scientific and budgetary oversight of all team activities, including prospective and retrospective observational studies to characterize disease burden and epidemiology, utilization of biomarkers and diagnostics, treatment patterns, health-care resource utilization and costs, physician and patient surveys, real world clinical and patient reported outcomes assessments. The role is also accountable for advancing and executing a precision medicine evidence generation strategy to generate high-quality data that inform patient care, identify evidence gaps, and support scientific and strategic decision-making. The Executive Director is expected to provide oversight for the development of Precision Medicine Outcomes Research plans and real-world evidence strategies that address cross-tumor/asset needs with a focus on generating evidence to advance patient care and identify unmet data needs and evidence gaps. Responsibilities and Primary Activities Leads, manages and provides scientific and strategic direction to teams leading the development and execution of high-quality evidence strategies and plans. Leads development and execution of Precision Medicine Outcomes Research plans that informs market decisions and that spans across tumor and asset needs. Ensures Outcomes Research plans deliver real world evidence that address cross-tumor/asset needs that informs market decisions in collaboration with tumor and asset teams, such as data quality assessment, federated data network development, and development of umbrella and adaptable protocols with V&I stakeholders to generate evidence that advances patient care and identifies unmet data needs/gaps. Develops a strong matrix relationship with clinical development, medical affairs, tumor and asset Outcomes Research, market access, biomarker, companion diagnostic, precision medicine commercial, and key markets to ensure that real world evidence informs market decisions related to our company's oncology medicines and associated biomarkers/diagnostics supporting access strategies and demonstrating value in real world settings Represents the perspectives and experiences of their team to shape the strategy and function of the outcomes research organization within the company through involvement in the extended leadership team and leading strategic initiatives that strengthen precision medicine evidence generation capabilities. Develop effective partnerships with internal stakeholders and external thought leaders in precision medicine and real-world evidence, to maintain our understanding of the external environment, inform our value evidence strategies and shape the environment for innovative applications. Maintains awareness of new scientific and methodological developments within Oncology and encourages appropriate application of new methods to real world evidence, including precision medicine studies to improve evidence generation and support patient care advancement. Maintains responsibility to ensure study conduct is aligned with company Policies and standard operating procedures